CLASS II Drug recall · Reported 22 Oct 2014 · FDA Enforcement Report

Ketorolac Tromethamine Injection, USP, 30 mg per mL, a) vial recalled

Sagent Pharmaceuticals is recalling Ketorolac Tromethamine Injection, USP, 30 mg per mL, a) vial (, distributed nationwide in the US. The recall was initiated on 3 Oct 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot MP5021, Exp. 04/16; Lots MP5024, MP5025, Exp. 05/16
NDC25021-700, 25021-701
Quantity recalled69,050 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0027-2015
FDA event ID
69485
Recalling firm
Sagent Pharmaceuticals, Schaumburg, IL
Manufacturer
Sagent Pharmaceuticals
Classification
Class II
Status
Terminated
Recall initiated
3 Oct 2014
FDA classified
16 Oct 2014
Reported
22 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons
Drug class
Pain Medication

Timeline

3 Oct 2014Recall initiated by company
16 Oct 2014Classified by FDA+13 days
22 Oct 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.

Product as listed by the FDA

Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.

Which lots are affected?

Lot MP5021, Exp. 04/16; Lots MP5024, MP5025, Exp. 05/16

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Sagent Pharmaceuticals

All 23

Other Ketorolac Tromethamine recalls

All 24